---

Highlights for October 2016

1. Piramal to buy Janssen's injectable anesthesia and pain management products for an upfront consideration of US$ 175 million.
2. Broncus Holding has acquired Uptake Medical Corp for the bronchoscopic ablation of emphysema and lung cancer.
3. Zydus group has entered into an in-licensing agreement with Neovii to launch Grafalon.
4. Daiichi Sankyo has entered into a new joint research agreement with Medicines for Malaria Venture regarding Lead Optimization Project
5. Intas buys the generics business of Actavis in the UK & Ireland for an enterprise value of US $ 667 Mn payable in cash
6. Agilent Technologies and Burning Rock partner on Molecular Diagnostics
7. Allergan to acquire Tobira Therapeutics expanding global GI R&D pipeline and taking a leading R&D position in NASH.
8. Eurolife snaps up Baxter’s form-fill-seal unit in India for an undisclosed price.